tiprankstipranks
Gilead Sciences (GB:0QYQ)
LSE:0QYQ
UK Market

Gilead Sciences (0QYQ) Financial Statements

Compare
1 Followers

Gilead Sciences Financial Overview

Gilead Sciences's market cap is currently $115.80B. The company's EPS TTM is $0.088; its P/E ratio is 1,048.37; and it has a dividend yield of 3.17%. Gilead Sciences is scheduled to report earnings on February 11, 2025, and the estimated EPS forecast is $1.71. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 27.12B$ 27.28B$ 27.30B$ 24.69B$ 22.45B
Gross Profit$ 20.62B$ 21.62B$ 20.70B$ 20.12B$ 17.77B
Operating Income$ 7.61B$ 7.33B$ 7.41B$ 7.03B$ 4.29B
EBITDA$ 10.50B$ 8.85B$ 11.33B$ 4.13B$ 7.56B
Net Income$ 5.67B$ 4.59B$ 6.22B$ 89.00M$ 5.39B
Balance Sheet
Cash & Short-Term Investments$ 7.26B$ 7.63B$ 7.83B$ 7.91B$ 25.84B
Total Assets$ 62.13B$ 63.17B$ 67.95B$ 68.41B$ 61.63B
Total Debt$ 24.99B$ 25.23B$ 26.70B$ 31.40B$ 24.59B
Net Debt$ 18.90B$ 19.82B$ 21.36B$ 25.41B$ 12.96B
Total Liabilities$ 39.38B$ 41.96B$ 46.89B$ 50.19B$ 38.98B
Stockholders' Equity$ 22.83B$ 21.21B$ 21.06B$ 18.22B$ 22.65B
Cash Flow
Free Cash Flow$ 7.42B$ 8.34B$ 10.80B$ 7.52B$ 8.32B
Operating Cash Flow$ 8.01B$ 9.07B$ 11.38B$ 8.17B$ 9.14B
Investing Cash Flow$ -2.27B$ -2.47B$ -3.13B$ -14.62B$ -7.82B
Financing Cash Flow$ -5.13B$ -6.47B$ -8.88B$ 770.00M$ -7.63B
Currency in USD

Gilead Sciences Earnings and Revenue History

Gilead Sciences Debt to Assets

Gilead Sciences Cash Flow

Gilead Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis